Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen Research Letter

  


Authors: Thompson, M. C.; Harrup, R. A.; Coombs, C. C.; Roeker, L. E.; Pu, J. J.; Choi, M. Y.; Barr, P. M.; Allan, J. N.; Šimkovič, M.; Leslie, L.; Rhodes, J.; Chong, E. A.; Kamdar, M.; Skarbnik, A.; Lansigan, F.; McCall, B.; Saja, K.; Dyer, M. J. S.; Walter, H. S.; Lefebure, M.; Thadani-Mulero, M.; Boyer, M.; Biondo, J.; Sail, K.; Manzoor, B. S.; Furman, R.; Bantilan, K. S.; Goy, A.; Feldman, T.; Labella, D.; Schuster, S. J.; Park, J.; Palomba, L.; Zelenetz, A.; Eyre, T. A.; Kater, A. P.; Seymour, J. F.; Mato, A. R.
Title: Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen
Journal Title: Blood Advances
Volume: 6
Issue: 15
ISSN: 2473-9529
Publisher: American Society of Hematology  
Date Published: 2022-08-09
Start Page: 4553
End Page: 4557
Language: English
DOI: 10.1182/bloodadvances.2022007812
PUBMED: 35736670
PROVIDER: scopus
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85135485099&doi=10.1182%2fbloodadvances.2022007812&partnerID=40&md5=a4f4f1db74262ab0d7b982a0253b746f
Notes: Letter -- Export Date: 1 September 2022 -- Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Maria Lia Palomba
    415 Palomba
  2. Jae Hong Park
    356 Park
  3. Andrew D Zelenetz
    767 Zelenetz
  4. Kurt Bantilan
    25 Bantilan
  5. Anthony R Mato
    235 Mato
  6. Lindsey Elizabeth Roeker
    132 Roeker
  7. Meghan Caitlin Thompson
    48 Thompson
Related MSK Work